Today's Must Read
Citigroup (C) Continues with Restructuring
Facebook's (FB) Messenger now Boasts 1 Billion Users
Thursday, July 21, 2016
We have hand-picked 14 research reports in today's Research Daily write-up from the roughly 80 reports issued by our analysts team today. This includes the 6 research reports featured below about Johnson & Johnson (JNJ), Citigroup (C), Facebook (FB), Novartis (NVS), Tesla (TSLA) and BHP Billiton (BHP).
Zacks Rank # 2 (Buy) rated Johnson & Johnson shares are up more than 20% year-to-date, with the momentum expected to continue to following the company's strong June quarter results. The analyst likes the company’s strategy of entering into several deals that hold the potential to boost its top line. The Cougar Biotechnology acquisition has allowed Johnson & Johnson to strengthen its oncology portfolio. A diversified business model, financial strength, new products and a deep pipeline are key elements of the JNJ story. (You can read the full research report on JNJ here.)
Citigroup shares have struggled this year, as have those of its peers, given the tough interest rate backdrop and uncertainty about the global ecnomic outlook. But the stock has got some of it mojo back following the better than expected second-quarter 2016 earnings report. The analyst likes the financial major’s capital strength, proven by the fact that it successfully cleared the 2016 Dodd-Frank Act Stress Test. A diverse business model, gradual offloading of non-core assets and streamlining of international businesses keep Citigroup's growth momentum alive. (You can read the full research report on C here.)
Facebook has been riding high on its growing user and advertisers’ base along with its other offerings like Instagram, Oculus, Messenger and WhatsApp. Recently, Messenger crossed the 1 billion user milestone, joining the likes of Facebook and WhatsApp. The analyst is encouraged by higher online and mobile advertising spending on the social network, its strong user base and robust balance sheet. (You can read the full research report on FB here.)
Other noteworthy reports we are featuring today include Novartis (NVS), Tesla (TSLA) and BHP Billiton (BHP).
- Novartis (NVS) Beats Q2 Earnings
- Tesla’s (TSLA) Master Plan Encouraging
- BHP Billiton (BHP) Upgraded to Zacks Rank # 2 (Buy)
You can find all of today's stock research reports here.
Director of Research
Note: Sheraz Mian regularly provides earnings analysis on Zacks.com and appears frequently in the print and electronic media. His weekly earnings related articles include Earnings Trends and Earnings Preview. He also provides weekly commentary to Zacks Premium subscribers and manages the Zacks Focus List and Top 10 portfolios.
If you want an email notification each time Sheraz publishes a new article, please click here.